Recent Patents on Anti-Cancer Drug Discovery
Volume 15, 4 Issues, 2020
ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)
This journal supports open access
ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Editor-in-Chief
Zhe-Sheng (Jason) Chen
Institute for Biotechnology
College of Pharmacy and Health Sciences
St. John's University
New York, NY
(USA)
Biography
Institute for Biotechnology
College of Pharmacy and Health Sciences
St. John's University
New York, NY
Biography
Biography of Zhe-Sheng (Jason) Chen
Dr. Chen obtained a doctorate (Ph.D.) in Pharmacology from the Kagoshima University, Japan. He also holds an MD degree from Guangdong Medical and Pharmaceutical College and a Master's degree in Toxicology from Sun Yat-Sen University, China. Currently, Dr. Chen is a Professor at St. John’s University College of Pharmacy and Health Sciences. He is also a director of the Institute for Biotechnology at St. John’s University. He has published more than 270 scientific publications. Besides, he is the founding Editor in Chief of the Journal of Cancer Research Updates, an Editor-in-Chief of the Journal of New Developments in Chemistry and an editor of the African Journal of Pharmacy and Pharmacology. He is also an editorial board member of 26 journals and a reviewer of more than 240 peer-reviewed journals.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Recent Patents on Anti-Cancer Drug Discovery was launched in 2006. Prof. Zhe-Sheng (Jason) Chen serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.52
Advertisement
Webmaster Contact: info@benthamscience.net